Back
NCR Voyix Corp. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
41
VYX
NCR Voyix Corp.
Last Price:
$10.35
Seasonality Move:
4.99%
Sell
29
ZBIO
Zenas BioPharma, Inc.
Last Price:
$35.81
Seasonality Move:
0.59%
Sell
41
NCR Voyix Corp. (VYX)
is a Sell
Is NCR Voyix Corp. a Buy, Sell or Hold?
-
The current NCR Voyix Corp. [VYX] share price is $10.34. The Score for VYX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
VYX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VYX Stock Price Chart
What is NCR Voyix Corp.'s stock price today?
-
The NCR Voyix Corp. share price today is $10.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $35.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.
VYX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.82 | Buy |
| Relative Strength Index (14 RSI): | 51.13 | Buy |
| Chaikin Money Flow: | 1914286 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.74 - 10.46) | Buy |
| Bollinger Bands (100): | (10.61 - 13.07) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 49.55 | Sell |
| Chaikin Money Flow: | -89322 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.22 - 39.36) | Sell |
| Bollinger Bands (100): | (17.16 - 33.88) | Buy |
VYX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.97 | Buy |
| 20-day SMA: | 9.96 | Buy |
| 50-day SMA: | 10.78 | Sell |
| 200-day SMA: | 11.32 | Sell |
| 8-day EMA: | 2.3 | Buy |
| 20-day EMA: | 0.98 | Buy |
| 50-day EMA: | 0.41 | Buy |
| 200-day EMA: | 0.1 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.84 | Sell |
| 20-day SMA: | 37.69 | Sell |
| 50-day SMA: | 32.84 | Buy |
| 200-day SMA: | 17.75 | Buy |
| 8-day EMA: | 7.96 | Buy |
| 20-day EMA: | 3.41 | Buy |
| 50-day EMA: | 1.4 | Buy |
| 200-day EMA: | 0.36 | Buy |
NCR Voyix Corp. Earnings Growth & VYX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $0.17 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
NCR Voyix Corp. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||